CereFlow (TM) is automated and multi-vendor post-processing solution for non-invasive MR Imaging featured by Arterial Spin Labeling (ASL), enables a fast evaluation of many pathophysiologies.

​

CereFlow (TM) offers quantitative and qualitative multi-parametric perfusion maps, and dynamic cerebral angiographic visualizations.

​

CereFlow (TM) is an intuitive, fast and accurate solution, improving clinical productivity and diagnostic process.

 

CereFlow (TM) is scheduled for FDA 510 (k) clearance in 2021.